---
document_datetime: 2023-09-21 21:08:23
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sildenafil-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: sildenafil-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 8.4540892
conversion_datetime: 2025-12-26 09:39:05.90122
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Sildenafil ratiopharm

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                     |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0052              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 21/06/2022                          |                                             | SmPC and PL                      | To update section 4.5 of the SmPC to add a warning about the increase in hypotension observed with concomitant use of sildenafil and sacubitril/valsartan. The Package Leaflet has been updated accordigly. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                          | 07/03/2022   | n/a   |    | IA/0051                  |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----|--------------------------|
| IA/0050   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                        | 04/02/2022   | n/a   |    |                          |
| N/0049    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                    | 21/09/2021   |       | PL |                          |
| IA/0048/G | This was an application for a group of variations. B.III.1.a.4 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Deletion of certificates (in case multiple certificates exist per material) B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate manufacturer | 22/06/2021   | n/a   |    | from an already approved |
| IA/0047/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure test procedure for the finished                                                                                                                        | 18/02/2021   | n/a   |    | B.II.d.2.a - Change in   |

<div style=\"page-break-after: always\"></div>

|           | - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                |            |            |                                  | product procedure   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------|
| IB/0046   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                     | 02/09/2020 | 29/09/2021 | SmPC, Annex II, Labelling and PL |                     |
| IB/0045   | B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                     | 11/06/2020 | n/a        |                                  |                     |
| IA/0044   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                        | 14/08/2019 | n/a        |                                  |                     |
| N/0043    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                   | 08/01/2019 | 29/09/2021 | Labelling and PL                 |                     |
| IB/0042   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                         | 25/10/2018 | n/a        |                                  |                     |
| IB/0041/G | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a | 24/07/2018 | n/a        |                                  |                     |

<div style=\"page-break-after: always\"></div>

|             | new manufacturer (replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                  |                                                   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|---------------------------------------------------|
| IB/0040/G   | for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished                                                                                                                                                                                                                                                                                                                                                                                                                             | 13/04/2018 | n/a        |                  | This was an application product - Other variation |
| N/0039      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 20/03/2018 | 29/09/2021 | Labelling and PL |                                                   |
| IAIN/0038/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 02/06/2017 | n/a        |                  |                                                   |

<div style=\"page-break-after: always\"></div>

| IB/0037   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                         | 06/01/2016   | 25/01/2016   | SmPC and PL               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0036/G | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test | 23/10/2015   | n/a          |                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| R/0035    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                              | 24/07/2014   | 09/09/2014   |                           | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP is of the opinion that the quality, safety and efficacy of Sildenafil ratiopharm continues to be adequately and sufficiently demonstrated and therefore considered that the benefit risk profile of Sildenafil ratiopharm continues to be favourable in the treatment of adult men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Sildenafil ratiopharm to be effective, sexual stimulation is required. The CHMP recommended the renewal of the Marketing Authorisation with unlimited validity. |
| IB/0033/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                   | 16/05/2014   | 09/09/2014   | SmPC, Annex II, Labelling |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes   |            |            | and PL      |                                                                                                                                                                                                                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0034 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                 | 28/03/2014 | n/a        |             |                                                                                                                                                                                                                |
| IA/0032/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                  | 25/02/2014 | n/a        |             |                                                                                                                                                                                                                |
| IB/0031   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                       | 17/10/2013 | 09/12/2013 | SmPC and PL | Update of Section 4.4 of the SmPC to revise the information on acute NAION based on new data coming from the clinical study A1481259 according to the Originator. The package leaflet was amended accordingly. |

<div style=\"page-break-after: always\"></div>

| IB/0030     | - Change in pack size of the finished - Change in the number of units (e.g. ampoules, etc.) in a pack - Change outside range of the currently approved pack sizes                                                                                                                                                                                                                                                                                                                                                                                                                                          | 30/08/2013   | 09/12/2013   | SmPC, Labelling and PL   | B.II.e.5.a.2 product tablets, the   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-------------------------------------|
| IA/0029     | B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral solutions                                                                                                                                                                                                                                                                                                                                                                                                                                          | 03/07/2013   | n/a          |                          | oral dosage form or                 |
| IA/0028     | B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions                                                                                                                                                                                                                                                                                                                                                                                                                      | 03/07/2013   | n/a          |                          |                                     |
| IAIN/0027/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.a.3.a.1 - Changes in the composition (excipients) of the finished product - Changes in components of the flavouring or colouring system - Addition , deletion or replacement C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a | 13/06/2013   | 09/12/2013   | SmPC, Annex II and PL    |                                     |

<div style=\"page-break-after: always\"></div>

|           | manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                |            |            |             |                                       |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------------------|
| IB/0022/G | application for a group of variations. B.II.a.1.b - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in scoring/break lines intended to divide into equal doses B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished | 08/05/2013 | 09/12/2013 | SmPC and PL | This was an product - Other variation |
| IB/0020/G | This was an application for a group of variations. B.II.a.2.a - Change in the shape or dimensions of the pharmaceutical form - Immediate release tablets, capsules, suppositories and pessaries B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished variation                                              | 08/05/2013 | 09/12/2013 | SmPC and PL | product - Other                       |
| II/0017   | To introduce substantial updates to the ASMF for sildenafil citrate, the active substance of Sildenafil ratiopharm. B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                         | 25/04/2013 | 25/04/2013 |             |                                       |
| IA/0026/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                      | 19/04/2013 | n/a        |             |                                       |

<div style=\"page-break-after: always\"></div>

|         | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the currently approved batch size B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the currently approved batch size B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the currently approved batch size   |            |            |                        |                                                                                                                                                                                                                                                                                    |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0024 | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                    | 17/04/2013 | n/a        |                        |                                                                                                                                                                                                                                                                                    |
| IA/0025 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                    | 12/04/2013 | n/a        |                        |                                                                                                                                                                                                                                                                                    |
| IB/0023 | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes                                                                                                                                                                                                                                                                             | 12/04/2013 | 09/12/2013 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                    |
| IB/0019 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                  | 06/03/2013 | 09/12/2013 | SmPC, Annex II and PL  | Implementation of changes approved in the reference product - update of section 4.8 to add ' Penile haemorrhage, Haematospermia, and Haematuria ' with an uncommon frequency and deletion of the footnote referring to ear disorders as requested by CHMP. The Package Leaflet was |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |                 | updated accordingly. The MAH also took the opportunity to make an editorial change to add the word ' anterior ' in section 4.4 for some languages and to update Annex II according to the latest QRD template.   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0018     | B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter                                                                                                                                                                                                                                                                                                                                                                                                                                                | 15/01/2013 | n/a        |                 |                                                                                                                                                                                                                  |
| IB/0015     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 08/01/2013 | 09/12/2013 | SmPC            |                                                                                                                                                                                                                  |
| IAIN/0016/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.b.2 - Change to batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site | 07/12/2012 | 09/12/2013 | Annex II and PL |                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

| IAIN/0014/G   | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)   | 25/06/2012   | n/a        |          |                                                                                                                                                                              |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0013        | Update of the local representatives contact details. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                   | 22/06/2012   | 09/12/2013 | PL       |                                                                                                                                                                              |
| IA/0012       | B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions                                                                                                                                                                                                                                                                                                                                                   | 14/12/2011   | n/a        |          |                                                                                                                                                                              |
| IA/0011       | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                                                                                                                                                                                                                                                                                            | 06/09/2011   | n/a        |          |                                                                                                                                                                              |
| II/0010       | Introduction of a new Pharmacovigilance System (TEVA DDPS Version 10), including a new Qualified person for Pharmacovigilance, which has not been                                                                                                                                                                                                                                                                                                                                                                                       | 23/06/2011   | 13/07/2011 | Annex II | The MAH has introduced a new pharmacovigilance system used by TEVA Pharmaceutical Industries Ltd., which will be applied for the product Sildenafil Ratiopharm. The detailed |

<div style=\"page-break-after: always\"></div>

|           | assessed yet by the CHMP for another product of the same MAH. Annex II.b has also been updated with the latest QRD template. C.I.8.a - Introduction of a new Pharmacovigilance system - which has not been assessed by the relevant NCA/EMA for another product of the same MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     | description of this pharmacovigilance system includes information pertaining to the qualified person responsible for pharmacovigilance, the global structure of the pharmacovigilance organisation, company procedures relating to pharmacovigilance activities, global safety databases, links with other organisations, training and the quality management system. The MAH has also taken the opportunity to update Annex II.b with the latest wording as per October 2010 CHMP procedural announcement.   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0008/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other | 28/10/2010 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| or addition) for the AS material/intermediate B.I.b.1.c - Change in and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.b.1.b - Change in and/or limits of an AS, material/intermediate/reagent specification limits B.I.a.4.c - Change to applied during the manufacture of a non-significant in-process B.I.b.1.c - Change in and/or limits of an AS, material/intermediate/reagent specification parameter corresponding test method B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.c - Change in and/or limits of an AS, material/intermediate/reagent   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|         | test method B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion non-significant in-process test                                                                                                                                                                                                          |            |     |             | corresponding of a   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|----------------------|
| IB/0009 | Update of section 4.8 of the Summary of Product Characteristics to include severe cutaneous adverse drug reactions, i.e. Stevens Johnson syndrome and Toxic epidermal necrolysis. The Package Leaflet is amended accordingly. In addition, the web address of the EMA has been updated in Section 10 of the SmPC and in the PL. These changes were made to bring Sildenafil ratiopharm's product information in line with the reference medicinal product Viagra. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 13/09/2010 | n/a | SmPC and PL |                      |

<div style=\"page-break-after: always\"></div>

| N/0006    | of the list of local representatives in the Leaflet in all EU languages due to the of the phone number of the local in the Netherlands change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                           | 02/06/2010   | n/a   | PL              | Update Package change representative Minor   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------|----------------------------------------------|
| IA/0007/G | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer responsible for batch release A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding batch release) | 12/05/2010   | n/a   | Annex II and PL | manufacturer for                             |
| IA/0005   | To add an additional site for secondary packaging B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                        | 12/05/2010   | n/a   |                 |                                              |
| IB/0002/G | This was an application for a group of variations. B.II.a.2.a - Change in the shape or dimensions of the pharmaceutical form - Immediate release tablets, capsules, suppositories and pessaries B.II.b.5.z - Change to in-process tests or limits manufacture of the finished                                                               | 12/03/2010   | n/a   | SmPC and PL     | applied during the                           |

<div style=\"page-break-after: always\"></div>

|           | product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IA/0001/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 18/02/2010 | 18/02/2010 | SmPC, Labelling and PL |